Antimony Volumes Climb 26% but Prices Cut Into UAMY Margins

United States Antimony Corp (NYSE American: UAMY) told investors on its fiscal Q2 2026 earnings call that antimony volumes surged about 26% and zeolite revenue doubled while liquidity strengthened to $62.2 million, but lower antimony prices compressed margins and led the company to reduce its full-year outlook.

United States Antimony Corp (NYSE American: UAMY) delivered the kind of quarter that separates operating progress from price leverage. On its fiscal second-quarter 2026 earnings call, the company said antimony volumes surged roughly 26%, revenue from its zeolite business doubled, and liquidity strengthened to $62.2 million. It also said lower antimony prices compressed margins and trimmed its full-year outlook.

Shares closed at $6.58 on Tuesday, 11 August 2026, down 1.35% from the prior close of $6.67, with the session range running from $6.45 to $6.78. That was a slightly heavier decline than the broad market: the S&P 500 tracker (SPY) closed at $770.56, off 0.32%, while the Nasdaq 100 proxy (QQQ) fell 0.34% to $718.45 and the Dow 30 fund (DIA) slipped 0.32% to $537.28. In other words, the stock did not break down on the print, but it did not get rewarded for the volume growth either.

Why more tons did not translate into more revenue

The arithmetic of a commodity processor is brutally simple. Revenue is tons multiplied by realized price. When volumes rise by a quarter and revenue still disappoints, the price line has moved against the company by enough to swallow the gain. That is precisely the picture the company described: volumes up sharply, pricing pressure weighing on revenue, and margins compressed as a result.

This matters more for a processor than for a pure miner with locked-in offtake. United States Antimony buys and processes feedstock as well as producing from its own operations, which means input costs and output prices can move on different clocks. When the metal price falls faster than feed costs adjust, the spread narrows immediately — and a business that has just scaled up throughput ends up running more material through a thinner margin.

Investors who bought the antimony story over the past two years bought it largely as a price story. Antimony is on the U.S. critical minerals list, is used in flame retardants, lead-acid batteries, ammunition primers and semiconductor dopants, and has been subject to export restrictions from China, the dominant global supplier. That backdrop drove a re-rating of Western processing capacity. What the second quarter shows is that the re-rating cuts both ways: the same operating leverage that magnifies rising prices magnifies falling ones.

The guidance cut is a pricing statement, not an operating one

The reduced full-year outlook deserves careful reading. Nothing in the company's account suggests volumes are the problem — they went up. The outlook came down because the price assumption behind it came down. For shareholders, that distinction is the whole story. An operating stumble would raise questions about permits, plant uptime and feedstock security. A price-driven revision leaves the asset base intact and simply resets the near-term earnings math.

The practical consequence is that any recovery in the guidance is likely to arrive from outside the company's control. If antimony prices firm, the volume growth already achieved becomes far more valuable, because the incremental tons flow through at a wider spread. If prices stay soft, more throughput mainly means more working capital tied up in inventory and receivables.

The details of the call were reported by GuruFocus.

What the $62.2 million liquidity position buys

The strongest number in the release is the balance sheet. Liquidity of $62.2 million is not a rounding item for a company of this size, and it changes the character of a weak pricing quarter. A processor with a thin cash position facing falling realized prices has to make defensive choices: slow expansion, stretch payables, or raise equity into a declining share price. A processor with a funded balance sheet can keep building while the cycle works against it.

That is the argument for looking past the margin compression. Capacity added during a soft price stretch is capacity that is already commissioned and ramped when prices recover. The risk is the mirror image — if the soft patch lasts longer than the cash runway comfortably supports, the same expansion becomes a fixed-cost burden.

Zeolite quietly does the diversification work

The doubling of zeolite revenue is easy to overlook next to antimony, but it is doing something useful. Zeolite is an industrial mineral used in water treatment, soil amendment, animal feed and odor control. Its pricing is not tethered to the critical-minerals trade cycle, and its customers are largely domestic and industrial rather than strategic.

A second revenue stream that doubles in a quarter when the primary stream is under pricing pressure is exactly the kind of ballast a single-commodity company needs. It will not offset antimony in absolute dollars any time soon, but it smooths the revenue line, spreads fixed overhead across more product, and gives management something to talk about that is not the metal price. Over several quarters, a growing zeolite base is the difference between a pure price proxy and a diversified minerals company.

The signposts that matter from here

For anyone tracking the name, a short list of things to watch:

Realized price per ton versus spot antimony. The gap between the two tells you how much of the pricing pressure is market and how much is contract mix or timing.
Whether volume growth holds at the new run rate. A 26% surge in a single quarter can reflect timing of shipments; two consecutive quarters at that level is a genuine capacity story.
The trajectory of the liquidity balance. If $62.2 million erodes quickly while prices are soft, the financing question returns.
Zeolite's contribution as a share of total revenue. The doubling is impressive in percentage terms; the number that matters is how large the base becomes.
Policy and trade developments. Antimony sits inside a live geopolitical argument about supply security, and government purchasing or stockpiling decisions can move the price assumption behind the guidance more than anything management does.

How to frame the stock at $6.58

The market's reaction — a 1.35% decline to $6.58 against a broad tape that was down about a third of a percent — reads as a mild derating rather than a repudiation. That is consistent with a market that already knew pricing was soft and was more interested in whether the operating build-out and the balance sheet were intact. On the evidence of the call, both are.

The honest framing is that United States Antimony is now a leveraged bet on the antimony price with a funded balance sheet and a second industrial-minerals business growing underneath it. The volume growth removes one bear argument — that the company could not scale. The guidance cut restates the remaining one: that the earnings outcome depends on a price the company does not set. Investors who accept that trade get an operationally improving business at a lower price. Those who wanted insulation from commodity swings did not get it this quarter.

Key facts

UAMY last close: $6.58, down 1.35%, as of 11 Aug 2026 20:00 GMT (NYSE American)
Liquidity: $62.2 million
Antimony volumes: Surged about 26% in fiscal Q2 2026
Guidance: Full-year outlook reduced on lower antimony prices

Frequently asked questions

What did United States Antimony report in fiscal Q2 2026?

On its fiscal second-quarter 2026 earnings call, United States Antimony said antimony volumes surged roughly 26% and zeolite revenue doubled, while liquidity strengthened to $62.2 million. Offsetting that, lower antimony prices compressed margins and weighed on revenue, prompting the company to reduce its full-year outlook.

Why did the company cut its full-year guidance?

The reduction was driven by pricing, not operations. Volumes rose during the quarter, but lower realized antimony prices compressed margins and pressured revenue. That means the guidance cut reflects a lower price assumption for the balance of the year rather than a problem with production capacity, plant uptime or demand for tons.

Where did UAMY shares close?

United States Antimony Corp shares closed at $6.58 on Tuesday, 11 August 2026, a decline of 1.35% from the previous close of $6.67. The stock traded between $6.45 and $6.78 during the session. The broad market was also lower, with the S&P 500 tracker down 0.32% at $770.56.

What is antimony used for?

Antimony is a critical mineral used in flame retardants, lead-acid batteries, ammunition primers and as a dopant in semiconductors. Because China has historically dominated global supply and has imposed export restrictions, Western processing capacity has attracted strategic and investor attention, which is a large part of the interest in United States Antimony.

Why does the zeolite business matter?

Zeolite is an industrial mineral used in water treatment, soil amendment, animal feed and odor control. Its pricing is not tied to the critical-minerals trade cycle, so a doubling of zeolite revenue provides ballast when antimony pricing is weak. It spreads fixed overhead and gradually reduces the company's dependence on a single commodity price.

What should investors watch next?

Key signposts include whether the 26% volume increase holds for a second quarter, how realized antimony prices track against spot, how quickly the $62.2 million liquidity position is drawn down, zeolite's growing share of total revenue, and any policy or trade developments affecting antimony supply security and pricing.

Sources

United States Antimony Corp (UAMY) (Q2 2026) Earnings Call Highlights: Antimony Volumes Surge ... — GuruFocus

Photo: Valentin Ilas · Pexels Licence — source